Compile Data Set for Download or QSAR
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 2143
TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355865(US9815840, Example 70 | N-(4-((5-(3-aminomethylphe...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355876(US9815840, Example 85 | N-(4-((5-(3-cyanomethylphe...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355875(US9815840, Example 83 | N-(4-((5-(5-amino-2-fluoro...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355874(US9815840, Example 82 | N-(4-((5-(3-amino-4-methox...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355873(US9815840, Example 81 | N-(4-((5-(3-((ethylamino)m...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355872(US9815840, Example 80 | N-(3-fluoro-4-((5-(3-((met...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355871(US9815840, Example 79 | N-(4-((5-(3-amino-2-methyl...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355870(US9815840, Example 78 | N-(4-((5-(3-amino-4-methyl...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355869(US9815840, Example 77 | N-(4-((5-(3-((dimethylamin...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355868(US9815840, Example 76 | N-(4-((5-(5-((dimethylamin...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355867(US9815840, Example 75 | N-(4-((5-(2-chloro-5-((dim...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355866(US9815840, Example 73 | N-(4-((5-(3-(ethylamino)ph...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355853(US9815840, Example 7 | 4-ethoxy-N-(3-fluoro-4-((5-...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355864(US9815840, Example 67 | N-(4-((5-(3-amino-5-cyanop...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355863(US9815840, Example 63 | N-(4-((5-(3-((dimethylamin...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355862(US9815840, Example 56 | N-(4-((5-(3-((dimethylamin...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355861(US9815840, Example 53 | 4-ethoxy-N-(3-fluoro-4-((5...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355860(US9815840, Example 50 | 4-ethoxy-N-(3-fluoro-4-((5...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355859(US9815840, Example 49 | 4-ethoxy-N-(3-fluoro-4-((5...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355858(US9815840, Example 47 | N-(3-fluoro-4-((5-(3-(1-hy...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355857(US9815840, Example 46 | 4-ethoxy-N-(3-fluoro-4-((5...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355856(US9815840, Example 43 | 4-ethoxy-N-(3-fluoro-4-((5...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355855(US9815840, Example 29 | N-(3-fluoro-4-((5-(3-hydro...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355854(US9815840, Example 23 | 4-ethoxy-N-(3-fluoro-4-((5...)
Affinity DataIC50: 40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent